The global scramble for chip capacity has entered its expensive second act: fabs rising on three continents, subsidies flowing, and the map of.

Microplastic particles have been detected in lungs, blood, placentas and brains. What scientists know, what they do not, and why the research is so hard.

After a raccoon attack, a 91-year-old patient discovered that lifesaving rabies vaccination was not covered and cost hundreds of dollars. Her case exposes the coverage gaps in post-exposure treatment and what patients need to know before they need it.

The same evolutionary trade-offs that gave humans language, planning and imagination also left the brain vulnerable to anxiety, degeneration and overload. We look at what our neural design costs us, and why it matters for mental health and ageing.

Ask what kept people alive at White Sands through an Ice Age of abrupt climate swings, and the evidence points to an unglamorous answer: flexibility.

Disease surveillance is America’s watchtower: unglamorous, continuously staffed, and noticed mainly when it fails.

The Netherlands’ gas boom gave economics one of its most famous warnings. We explain how resource earnings lift a currency, squeeze exporters and why rules-based saving helped countries like Norway escape the pattern.

Does switching to electronic cigarettes after quitting smoking leave a residual lung cancer risk? This review separates laboratory signals from human data and explains why former smokers complicate every study.

NeoVax combined with nivolumab was feasible and acceptably safe in a phase 1 ovarian cancer trial, with T-cell responses seen. Early evidence, carefully read.

A multi-year Canada-France-Hawaii Telescope survey has confirmed 128 new Saturn moons, taking the total to 274. How shift-and-stack imaging made it possible.